EVOGENE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280.1 ILa | -3.41% |
|
+11.55% | -6.57% |
| 05-23 | Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M | MT |
| 05-23 | Evogene Ltd. Provides Revenue Guidance for the Year 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOGENE LTD. | Other Biotechnology & Medical Research | -3.41% | +11.55% | -6.57% | +19.19% | -54.92% | 39.96M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- EVGN Stock
- Charts Evogene Ltd.
- Comparison Chart
